FDA Inspection 1270788 — Shreyas Ketkar, M.B.B.S
The FDA completed an inspection of Shreyas Ketkar, M.B.B.S on March 29, 2025 in Pune. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pune (India)
Additional Details
Clinical BA/BE